Generic Name

fentaNYL (transdermal)

Trade Name Duragesic

Class Opioid anagesics

Dose and Frequency

IVP RATE OF ADMIN.

TIME DUE
apnea, bronchoconstriction,
MOST IMPORTANT laryngospasm, confusion,
Side Effects sedation, weakness

Assess type, location, and intensity of pain

before and 24 hr after application and
Nursing Interventions periodically during therapy. Monitor pain
frequently during initiation of therapy and dose
changes to assess need for supplementary
analgesics for breakthrough pain.
Assess BP, pulse, and respirations before and
periodically during administration. If respiratory
rate is <10/min, assess level of sedation.
Physical stimulation may be sufficient to
prevent significant hypoventilation. Dose may
need to be decreased by 2550%. Initial
drowsiness will diminish with continued use
Specific Reason pt pain
receiving